PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma
Clinical trial NCT01621490 · COMPLETED
Trial details
- NCT number
- NCT01621490
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-27
- Primary completion
- 2017-09-12
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.